Drug Profile


Alternative Names: MDL 72222

Latest Information Update: 04 Sep 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Aventis
  • Class Antiemetics; Antimigraines; Small molecules; Tropanes
  • Mechanism of Action Serotonin 3 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Alzheimer's disease; Anxiety disorders; Nausea and vomiting

Most Recent Events

  • 20 Nov 1999 Discontinued - Phase-III for Emesis in USA (IV)
  • 20 Nov 1999 Discontinued - Preclinical for Anxiety disorders in USA (IV)
  • 20 Nov 1999 Discontinued for Alzheimer's disease in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top